<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Tenax Therapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Tenax Therapeutics, Inc.

    Tenax Therapeutics is focused on developing and commercializing pharmaceutical products that improve outcomes for patients with high unmet medical needs. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      8731
    • NIN CODE
      ####
    • LEADERSHIP
      Anthony DiTonno
    • FOUNDED
      1967
    • EMPLOYEES
      0-10
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Ambu A/S

    Ambu A/S

    Ambu A/S engages in the development, production, and marketing of diagnostic and l...

    Ambu A/S engages in the development, production...

    Filing Type:    PU
    RTI Surgical Holdings, Inc.

    RTI Surgical Holdings, Inc.

    RTI Surgical Holdings, Inc. is a leading global surgical implant company providing...

    RTI Surgical Holdings, Inc. is a leading global...

    Filing Type:    PU
    BioLife Solutions, Inc.

    BioLife Solutions, Inc.

    BioLife Solutions is the leading developer, manufacturer and supplier of proprieta...

    BioLife Solutions is the leading developer, man...

    Filing Type:    PU
    Soligenix, Inc.

    Soligenix, Inc.

    Soligenix, Inc. is a late-stage biopharmaceutical company focused on developing an...

    Soligenix, Inc. is a late-stage biopharmaceutic...

    Filing Type:    PU
    Marker Therapeutics, Inc.

    Marker Therapeutics, Inc.

    We are a clinical-stage immuno-oncology company specializing in the development an...

    We are a clinical-stage immuno-oncology company...

    Filing Type:    PU
    Gemphire Therapeutics Inc.

    Gemphire Therapeutics Inc.

    Gemphire Therapeutics Inc. (NASDAQ:GEMP) is a clinical‑stage biopharmaceutical c...

    Gemphire Therapeutics Inc. (NASDAQ:GEMP) is a c...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.